H Burgmann

Summary

Affiliation: Medical University of Vienna
Country: Austria

Publications

  1. ncbi request reprint [New antibiotics for severe sepsis--the break-through?]
    H Burgmann
    Innere Medizin I, Klinische Abteilung für Infektionen und Tropenmedizin, Medizinische Universität Wien, Wahringer Gurtel 18 20, A 1090 Wien
    Dtsch Med Wochenschr 133:372-3. 2008
  2. doi request reprint Hospital antibiotic management in Austria--results of the ABS maturity survey of the ABS International group
    Heinz Burgmann
    Medizinische Universität Wien, and Donauspital im Soxialmedizinischen Zentrum Ost, Vienna, Austria
    Wien Klin Wochenschr 120:280-3. 2008
  3. doi request reprint Likelihood of inadequate treatment: a novel approach to evaluating drug-resistance patterns
    Heinz Burgmann
    Division of Intensive Care, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
    Infect Control Hosp Epidemiol 30:672-7. 2009
  4. ncbi request reprint Continuous infusion versus intermittent administration of meropenem in critically ill patients
    F Thalhammer
    Department of Internal Medicine I, University of Vienna, Austria
    J Antimicrob Chemother 43:523-7. 1999
  5. ncbi request reprint Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit
    T Staudinger
    Department of Internal Medicine I, University of Vienna, Austria
    Crit Care Med 28:1322-8. 2000
  6. pmc Daptomycin, fosfomycin, or both for treatment of methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model
    W Poeppl
    Department of Internal Medicine I, Division of Infectious Diseases, Medical University of Vienna, Vienna, Austria
    Antimicrob Agents Chemother 55:4999-5003. 2011
  7. ncbi request reprint Diagnostic validity of pulmonary artery catheterization for residents at an intensive care unit
    T Staudinger
    Department of Internal Medicine I, University of Vienna, Austria
    J Trauma 44:902-6. 1998
  8. doi request reprint Effectiveness and immunogenicity of pneumococcal vaccination in splenectomized and functionally asplenic patients
    C Forstner
    Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Waehringer Gurtel 18 20, 1090 Vienna, Austria
    Vaccine 30:5449-52. 2012
  9. doi request reprint Immunogenicity of a combined schedule of 7-valent pneumococcal conjugate vaccine followed by a 23-valent polysaccharide vaccine in adult recipients of heart or lung transplants
    R Gattringer
    Department of Medicine I, Division of Infectious Diseases, Medical University of Vienna, Vienna, Austria
    Transpl Infect Dis 13:540-4. 2011
  10. doi request reprint Seroprevalence and asymptomatic carriage of Leishmania spp. in Austria, a non-endemic European country
    W Poeppl
    Department of Infectious Diseases and Tropical Medicine, Medical University of Vienna Department of Dermatology and Tropical Medicine, Military Hospital Vienna Department of Emergency Medicine, Medical University of Vienna Institute for Medical Support, Military Hospital Vienna Institute of Specific Prophylaxis and Tropical Medicine, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria
    Clin Microbiol Infect 19:572-7. 2013

Collaborators

Detail Information

Publications28

  1. ncbi request reprint [New antibiotics for severe sepsis--the break-through?]
    H Burgmann
    Innere Medizin I, Klinische Abteilung für Infektionen und Tropenmedizin, Medizinische Universität Wien, Wahringer Gurtel 18 20, A 1090 Wien
    Dtsch Med Wochenschr 133:372-3. 2008
  2. doi request reprint Hospital antibiotic management in Austria--results of the ABS maturity survey of the ABS International group
    Heinz Burgmann
    Medizinische Universität Wien, and Donauspital im Soxialmedizinischen Zentrum Ost, Vienna, Austria
    Wien Klin Wochenschr 120:280-3. 2008
    ..The ABS International group conducted a survey to estimate the prevalence and characteristics of country-specific hospital antibiotic management programs. This paper summarizes the results for Austria...
  3. doi request reprint Likelihood of inadequate treatment: a novel approach to evaluating drug-resistance patterns
    Heinz Burgmann
    Division of Intensive Care, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
    Infect Control Hosp Epidemiol 30:672-7. 2009
    ..To provide a novel way to predict the likelihood that antibiotic therapy will result in prompt, adequate therapy on the basis of local microbiological data...
  4. ncbi request reprint Continuous infusion versus intermittent administration of meropenem in critically ill patients
    F Thalhammer
    Department of Internal Medicine I, University of Vienna, Austria
    J Antimicrob Chemother 43:523-7. 1999
    ..We conclude that CI of meropenem is equivalent to the IA regimen and is therefore suitable for treating critically ill patients. Further studies are necessary to compare the clinical effects of CI and IA in this patient group...
  5. ncbi request reprint Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit
    T Staudinger
    Department of Internal Medicine I, University of Vienna, Austria
    Crit Care Med 28:1322-8. 2000
    ....
  6. pmc Daptomycin, fosfomycin, or both for treatment of methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model
    W Poeppl
    Department of Internal Medicine I, Division of Infectious Diseases, Medical University of Vienna, Vienna, Austria
    Antimicrob Agents Chemother 55:4999-5003. 2011
    ..No synergistic or antagonistic effect was observed for the combination therapy. No development of resistance against daptomycin or fosfomycin was observed after the 4-week treatment period...
  7. ncbi request reprint Diagnostic validity of pulmonary artery catheterization for residents at an intensive care unit
    T Staudinger
    Department of Internal Medicine I, University of Vienna, Austria
    J Trauma 44:902-6. 1998
    ..To assess the amount of additional information provided by measurements derived from pulmonary artery catheter (PAC) use beyond that derived from clinical evaluation by intensive care residents...
  8. doi request reprint Effectiveness and immunogenicity of pneumococcal vaccination in splenectomized and functionally asplenic patients
    C Forstner
    Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Waehringer Gurtel 18 20, 1090 Vienna, Austria
    Vaccine 30:5449-52. 2012
    ..Nevertheless, post-vaccine pneumococcal sepsis was still diagnosed in 3.3% of splenectomized survivors...
  9. doi request reprint Immunogenicity of a combined schedule of 7-valent pneumococcal conjugate vaccine followed by a 23-valent polysaccharide vaccine in adult recipients of heart or lung transplants
    R Gattringer
    Department of Medicine I, Division of Infectious Diseases, Medical University of Vienna, Vienna, Austria
    Transpl Infect Dis 13:540-4. 2011
    ..PCV7 was immunogenic in these patients but there appeared to be no benefit from the additional PPV23 dose...
  10. doi request reprint Seroprevalence and asymptomatic carriage of Leishmania spp. in Austria, a non-endemic European country
    W Poeppl
    Department of Infectious Diseases and Tropical Medicine, Medical University of Vienna Department of Dermatology and Tropical Medicine, Military Hospital Vienna Department of Emergency Medicine, Medical University of Vienna Institute for Medical Support, Military Hospital Vienna Institute of Specific Prophylaxis and Tropical Medicine, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria
    Clin Microbiol Infect 19:572-7. 2013
    ..was found for travel to the New World, particularly to the Caribbean. Our data demonstrate that Leishmania spp. seroprevalence in non-endemic countries has been considerably underestimated...
  11. pmc Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration
    F Thalhammer
    Department of Internal Medicine I, Division of Infectious Diseases, University of Vienna, A 1090 Vienna, Austria
    Antimicrob Agents Chemother 42:2417-20. 1998
    ..Based on these data, we conclude that patients with severe infections who are undergoing CVVH can be treated effectively with 1 g of meropenem every 8 h...
  12. ncbi request reprint The assessment of four different methods to verify tracheal tube placement in the critical care setting
    S Knapp
    Department of Internal Medicine I, University of Vienna, Austria
    Anesth Analg 88:766-70. 1999
    ....
  13. doi request reprint Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence
    C Forstner
    Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Waehringer Gurtel 18 20, Vienna, Austria
    Clin Microbiol Infect 19:E291-7. 2013
    ..Pharmacokinetic parameters seem to be decisive on microbiological and clinical success...
  14. doi request reprint Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria
    W Poeppl
    Department of Internal Medicine, Medical University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
    Infection 39:341-52. 2011
    ..To describe the clinical features, risk factors for severe disease and effectiveness of oseltamivir in patients with 2009 pandemic influenza A (H1N1) virus infection...
  15. doi request reprint Pre- and post-pandemic prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in Austrian adults
    W Poeppl
    Department of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Austria
    J Med Virol 84:1331-4. 2012
    ....
  16. ncbi request reprint Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers
    F Thalhammer
    Department of Internal Medicine I, Vienna Medical School, Austria
    Am J Kidney Dis 32:642-5. 1998
    ..We conclude that the type of dialyzer used has to be taken into account in dosage recommendations for antimicrobial therapy in hemodialysis patients...
  17. doi request reprint In vitro activity of doripenem plus fosfomycin against drug-resistant clinical blood isolates
    T Lingscheid
    Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria
    Pharmacology 91:214-8. 2013
    ..Selected isolates demonstrated synergism in time-kill curve tests. P. aeruginosa isolates demonstrated no interaction in all isolates. Doripenem plus fosfomycin shows high efficacy with promising results in vitro...
  18. ncbi request reprint [Prevention and therapy of infections in tumor patients]
    H Burgmann
    Klinische Abteilung für Infektionen und Chemotherapie, Universitätsklinik für Innere Medizin I, Wahringer Gurtel 18 20, A 1090 Wien
    Wien Med Wochenschr 151:600-14. 2001
    ..Vaccination should be emphasized in these patients...
  19. doi request reprint Comparative in vitro antimicrobial activity of vancomycin, teicoplanin, daptomycin and ceftobiprole in four different peritoneal dialysis fluids
    S Tobudic
    Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
    Eur J Clin Microbiol Infect Dis 31:1327-34. 2012
    ..Ceftobiprole showed no killing activities in any of the four PDFs. Based on these in vitro data we conclude that the choice of PDFs for intraperitoneal administration is not trivial and could be crucial for therapy outcome...
  20. doi request reprint National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases
    P Rendi-Wagner
    Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology, Medical University of Vienna, A 1090 Vienna, Austria
    Vaccine 27:3963-8. 2009
    ..Antimicrobial resistance predominated against erythromycin (32.5%) and clarithromycin (26.7%). Our data show that this risk group vaccination program had no impact on the incidence of IPD in young children...
  21. doi request reprint Clinical findings and management of imported cutaneous leishmaniasis: Report of 14 cases from Austria
    W Poeppl
    Department of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Waehringerguertel 18 20, 1090 Vienna, Austria
    Travel Med Infect Dis 11:90-4. 2013
    ..The management of cutaneous leishmaniasis in non-endemic countries is challenging due to the wide variety of clinical manifestations and little information available on treatment modalities for travellers...
  22. pmc Efficacy of fosfomycin in experimental osteomyelitis due to methicillin-resistant Staphylococcus aureus
    W Poeppl
    Department of Internal Medicine I, Division of Infectious Diseases, Medical University of Vienna, Vienna, Austria
    Antimicrob Agents Chemother 55:931-3. 2011
    ..2%) fosfomycin-treated rats. Thus, fosfomycin treatment was significantly more efficacious than placebo. No development of resistance was observed after the 4-week treatment period...
  23. ncbi request reprint Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2
    G J Locker
    Department of Internal Medicine I, Division of Oncology, University Hospital of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Eur Cytokine Netw 11:391-6. 2000
    ..Although anti-inflammatory responses accompany this process, they are not able to diminish the production of nitric oxide...
  24. ncbi request reprint Sepsis-associated purpura fulminans in adults
    G Gamper
    Department of Emergency Medicine, Vienna General Hospital University of Vienna, Medical School, Vienna, Austria
    Wien Klin Wochenschr 113:107-12. 2001
    ..Scoring systems developed for patients with meningococcal septicemia are of limited value in the setting of sepsis-associated purpura fulminans...
  25. ncbi request reprint Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosage
    B Meyer
    Department of Internal Medicine I, Division of Infectious Diseases, University of Vienna, Austria
    Int J Clin Pharmacol Ther 42:556-60. 2004
    ..It is unclear whether the use of a filter for more than 24 hours might lead to less efficient extraction. This study describes the pharmacokinetics of teicoplanin during CVVH using a highly permeable membrane...
  26. ncbi request reprint ["Antibiotic resistance"]
    H Burgmann
    Wien Med Wochenschr 153:143. 2003
  27. ncbi request reprint Contamination of central venous catheters in immunocompromised patients: a comparison between two different types of central venous catheters
    B Stoiser
    Department of Internal Medicine I Division of Infectious Diseases and Chemotherapy, University of Vienna, Austria
    J Hosp Infect 50:202-6. 2002
    ..The differences between the two groups were not significant. We conclude that the SC decrease the incidence of catheter contamination and may have a positive effect on the reduction of CVC-related infections...
  28. ncbi request reprint Molecular and clinical characterisation of homocystinuria in two Austrian families with cystathionine beta-synthase deficiency
    U Tröndle
    Department of Laboratory Medicine, Division of Endocrinology and Metabolism, University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna
    Acta Med Austriaca 28:145-51. 2001
    ..Both genotypes do not allow for normalisation of total homocysteine plasma levels following vitamin therapy...